Research Catalog · peptide family
AQEE Peptides (VGF-Derived) — Research Products
5 catalog items
| Catalog # | Product | Type | Species | Size | Price | Add to cart |
|---|---|---|---|---|---|---|
| 007-81 | AQEE-30 (Rat) | Peptides | Rat | 100 µg | $341.00 | |
| 007-72 | prepro-VGF (586-596) / AQEE-11 (Human) | Peptides | Human | 200 µg | $163.00 | |
| 007-70 | prepro-VGF (586-615) / AQEE-30 (Human) | Peptides | Human | 100 µg | $341.00 | |
| RK-007-70 | prepro-VGF (586-615) / AQEE-30 (Human) – RIA Kit RIA kit | Assay Kits | Human | 125 tubes | $942.00 | |
| 007-73 | prepro-VGF (597-615) / AQEE-19 (Human) | Peptides | Human | 200 µg | $202.00 |
All items are supplied for in vitro laboratory research use only — not for human or veterinary use, diagnosis or therapy. Prices are per unit as listed; each catalog number ships with its Certificate of Analysis.
AQEE Peptides (VGF-Derived) — frequently asked
What are AQEE peptides?
AQEE peptides are C-terminal fragments of the neurosecretory protein VGF. The names combine the first residues of the sequence with its length, so AQEE-30 corresponds to prepro-VGF residues 586 to 615, with AQEE-19 and AQEE-11 as shorter products.
Why are VGF-derived peptides studied?
VGF expression is induced by neurotrophins and its processing products are released in an activity-dependent way. Rodent studies associate them with energy balance, synaptic plasticity, pain signalling and neurogenesis, and altered levels have been reported in neurological research cohorts.
Why are several overlapping fragments offered?
VGF is cleaved at multiple internal sites, producing overlapping peptides that antibodies and immunoassays may not distinguish. Supplying AQEE-30, AQEE-19 and AQEE-11 separately lets researchers calibrate fragment-specific assays and compare activity across different processing products.